Wed, 2nd Apr 2008 08:38 LONDON (Thomson Financial) - Abcam Plc., which markets antibodies via an online catalogue, sai
d non-executive chairman David Cleevely has sold 600,000 shares in the company at 345 pence each to institutional investors.
Following the sale, Cleevely holds about 3.57 million shares, or 10.19 percent of the company's issued share capital.
TFN.newsdesk@thomson.com
bmi/bsu/slm
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.